Surveillance du cancer de l’endomètre

Gauthier, Tristan; Siegerth, François; Monteil, Jacques; Jammet, I.; Saïdi, N.; Tubiana-Mathieu, Nicole; Aubard, Y.

doi:10.1684/bdc.2014.1947

Cited by 2 publications

(6 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This blockage can happen because of surgery, radiotherapy or even tumor cells in the lymphatics. This has been shown in many studies comparing lymphatic drainage of the breast before and after breast surgery for cancer, which showed that deformed lymphatic drainage is common after surgery [4,12].…”

Section: Case Reportmentioning

confidence: 77%

“…It is important to perceive that contralateral regional metastasis occurs mainly by lymphatic spread in most patients, and not by hematogenous spread [4]. This is supported by many experimental studies [4,12].…”

Section: Case Reportmentioning

confidence: 94%

“…Because contralateral spread of crossed the midline of a unilateral cancer implies hematologic spread, axillary lymph nodes metastasized from the opposite breast cancer have been regarded as an evidence of systemic disease [3]. But, by reviewing the related literature, we came to understand that the contralateral regional lymph node metastasis can be thought of not only as hematogenous spread but also lymphatic spread [1,4,5]. Blockage of or damage to the usual lymphatic system might lead to the development of alternative routes of drainage.…”

Section: Case Reportmentioning

confidence: 99%

“…To follow the traditional principle, contralateral regional metastasis is systemic disease, and it should be treated with systemic therapy, not with local control [3]. But, by reviewing the related literature, we got to know that the contralateral regional metastasis can be mainly due to lymphatic spread [1,4,5], so we intend to suggest an alternative way to approach contralateral regional metastasis. mammography and breast ultrasonography should be included in the imaging work-up [8].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Breast Cancer with Delayed Metastasis Only to Contralateral Regional Lymph Nodes: A Case Report and Review of the Literature

Lee

Kim

et al. 2013

J Breast Dis

View full text Add to dashboard Cite

Delayed metastasis only to contralateral regional lymph nodes of a unilateral breast cancer has been considered as a systemic metastasis or a regional metastasis from contralateral primary occult breast cancer. This staging uncertainty has complicated for clinicians to choose treatment regimens for it. We report a case of a 52-year-old woman with metastasis only to contralateral regional lymph nodes 20 months after prior treatment of a unilateral breast cancer. She was treated with lymph node dissection, radiation therapy, chemotherapy, and hormonal therapy. Now 13 months after second surgery, the patient is alive without any evidence of breast cancer recurrence or metastasis. We suggest that solitary contralateral regional metastasis, especially post-breast-conserving surgery followed by radiation therapy, should be considered not only as hematogenous spread but also lymphatic spread. Although controversial, lymph node dissection for the delayed metastasis of breast cancer only to the contralateral regional lymph nodes can be of curative intent.

show abstract

Section: Case Reportmentioning

confidence: 77%

Section: Case Reportmentioning

confidence: 94%

Section: Case Reportmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Breast Cancer with Delayed Metastasis Only to Contralateral Regional Lymph Nodes: A Case Report and Review of the Literature

Lee

Kim

et al. 2013

J Breast Dis

View full text Add to dashboard Cite

show abstract

“…Les patientes récidivant de façon métastatique seraient symptomatiques dans 70% des cas. La réalisation d'un examen clinique rigoureux lors de chaque visite paraît indispensable [13]. Dans notre pratique, les récidives sont aussi diagnostiquées tardivement que les tumeurs primitives du fait du niveau de vie des populations et de l'analphabétisme.…”

Section: Discussionunclassified

Traitement des cancers de l’endomètre à l’institut Joliot Curie de Dakar : à propos de 30 cas

Thiam¹,

Kahatwa²,

Ka³

et al. 2021

Af J Oncol

View full text Add to dashboard Cite

AIM: To study the therapeutic aspects of endometrial cancer at the Joliot Curie Institute in Dakar. MATERIALS AND METHODS: This is a retrospective study conducted at the Joliot Curie Institute in Dakar including all cases of endometrial cancer confirmed by histology between January 2012 and December 2016. RESULTS: There were 30 cases of endometrial cancer over a period of five years. Endometrioid adenocarcinoma was the most common type of histology and was found in 25 patients, or 84% of cases. The patients were classified as stages I and II of FIGO in 43% of cases, stage III in 24% of cases and stage IV in 33% of cases. Colpo-hysterectomy with pelvic lymphadenectomy (CHL) was the main surgical procedure performed. External radiotherapy was performed in three patients or 10%. A case of radiation cystitis and radiodermatitis were recorded as a radiotherapy complication. No patient received brachytherapy. Chemotherapy was performed in 17 patients, ie 56.6%. She was adjuvant in 10 patients, or 34% of cases. Pelvic recurrences were noted in three patients who underwent 10% surgery. After 13 months of follow-up, survival was 50%. CONCLUSION: The most effective treatment modality for endometrial cancer at the Joliot Curie Institute was surgery followed by chemotherapy and Radiation therapy.

show abstract

Surveillance du cancer de l’endomètre

Cited by 2 publications

References 51 publications

Breast Cancer with Delayed Metastasis Only to Contralateral Regional Lymph Nodes: A Case Report and Review of the Literature

Breast Cancer with Delayed Metastasis Only to Contralateral Regional Lymph Nodes: A Case Report and Review of the Literature

Traitement des cancers de l’endomètre à l’institut Joliot Curie de Dakar : à propos de 30 cas

Contact Info

Product

Resources

About